Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DMHS | ISIN: US37733W2044 | Ticker-Symbol: GS70
Siehe auch GSK PLC
Tradegate
25.03.24
19:17 Uhr
40,000 Euro
+0,200
+0,50 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
GSK PLC ADR Chart 1 Jahr
5-Tage-Chart
GSK PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
39,80040,00018:52
39,80040,00017:58

Aktuelle News zur GSK PLC ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13:58Akebia joins GSK in US market for oral CKD anaemia drugs6
DiPeering Into GSK's Recent Short Interest4
DiGSK PLC - Director/PDMR Shareholding4
MoNSE - GSK Consumer Healthcare Capital US LLC - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities5
MoGSK plc - 6-K, Report of foreign issuer1
MoGSK PLC - Notice of AGM4
MoCan GSK and AstraZeneca stay competitive in tomorrow's pharma market?17
SaCovid-19 anniversary: How have GSK and Astrazeneca fared since?7
FrAfter GSK acquisition, Bellus CEO seeks work opportunities for displaced staff11
FrGSK PLC - Transfer of Treasury Shares6
FrGSK PLC - Director/PDMR Shareholding2
21.03.GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US2
21.03.GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month23
21.03.Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month6
21.03.Sosei Regains Full Ownership From GSK Of Clinic-Ready GPR35 Agonist For Inflammatory Bowel Disease385LONDON (dpa-AFX) - Sosei Group Corp. said it has regained full ownership from GSK of HTL0027477 (formerly GSK4381406), a clinic-ready, highly selective, first-in-class, oral GPR35 agonist in...
► Artikel lesen
21.03.Sosei Group Corporation: Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease58GPR35 is a novel target with an established genetic association to IBDUK regulatory approval received to commence first-in-human studiesReturn of rights follows change in immunology research strategy...
► Artikel lesen
20.03.GSK to cap out-of-pocket inhaler costs in US7
20.03.GSK Outperforms Industry on Strength in Key Drugs & Vaccines9
19.03.GSK's Jemperli regimens demonstrate potential for wider endometrial cancer use4
18.03.Move over 'Greediad', GSK is now under alliterative fire from the AIDS Healthcare Foundation7
Seite:  Weiter >>
730 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1